APA
Masuda T., Ohara K., Nagayama I., Matsuoka R., Murakami T., Nakagawa S., Oka K., Asakura M., Igarashi Y., Fukaya Y., Miyazawa Y., Maeshima A., Akimoto T., Saito O. & Nagata D. (20200227). Impact of serum albumin levels on the body fluid response to tolvaptan in chronic kidney disease patients. : International urology and nephrology.
Chicago
Masuda Takahiro, Ohara Ken, Nagayama Izumi, Matsuoka Ryo, Murakami Takuya, Nakagawa Saki, Oka Kentanro, Asakura Maki, Igarashi Yusuke, Fukaya Yukimura, Miyazawa Yasuharu, Maeshima Akito, Akimoto Tetsu, Saito Osamu and Nagata Daisuke. 20200227. Impact of serum albumin levels on the body fluid response to tolvaptan in chronic kidney disease patients. : International urology and nephrology.
Harvard
Masuda T., Ohara K., Nagayama I., Matsuoka R., Murakami T., Nakagawa S., Oka K., Asakura M., Igarashi Y., Fukaya Y., Miyazawa Y., Maeshima A., Akimoto T., Saito O. and Nagata D. (20200227). Impact of serum albumin levels on the body fluid response to tolvaptan in chronic kidney disease patients. : International urology and nephrology.
MLA
Masuda Takahiro, Ohara Ken, Nagayama Izumi, Matsuoka Ryo, Murakami Takuya, Nakagawa Saki, Oka Kentanro, Asakura Maki, Igarashi Yusuke, Fukaya Yukimura, Miyazawa Yasuharu, Maeshima Akito, Akimoto Tetsu, Saito Osamu and Nagata Daisuke. Impact of serum albumin levels on the body fluid response to tolvaptan in chronic kidney disease patients. : International urology and nephrology. 20200227.